It should be mentioned here, that CSF S100B may only be treated as a non-specific marker of glial activation and/or degeneration in PD, taking into account its moderate discrimination ability, but also the fact, that increased CSF S100B were also found in different other neurodegenerative disorders. Here, S100B is linked to Parkinson disease.